Showing 60,081 - 60,100 results of 111,445 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( a ((fold decrease) OR (point decrease)) ))', query time: 1.50s Refine Results
  1. 60081

    Table_3_Intravenous Infusion of Lidocaine for Bowel Function Recovery After Major Colorectal Surgery: A Critical Appraisal Through Updated Meta-Analysis, Trial Sequential Analysis,... by Po-Chuan Chen (775098)

    Published 2022
    “…IVF-Lido significantly decreased the time to first flatus [mean difference (MD) = −6.03 h; 95% confidence interval (CI): (−8.80, −3.26)] and first defecation [MD = −10.49 h; 95% CI: (−15.58, −5.41)]. …”
  2. 60082

    Table_2_Intravenous Infusion of Lidocaine for Bowel Function Recovery After Major Colorectal Surgery: A Critical Appraisal Through Updated Meta-Analysis, Trial Sequential Analysis,... by Po-Chuan Chen (775098)

    Published 2022
    “…IVF-Lido significantly decreased the time to first flatus [mean difference (MD) = −6.03 h; 95% confidence interval (CI): (−8.80, −3.26)] and first defecation [MD = −10.49 h; 95% CI: (−15.58, −5.41)]. …”
  3. 60083

    Data Sheet 1_Profile and risk factors of blood donors who experienced adverse reactions: a cross-sectional study on donor hemovigilance data reported to the national network from 2... by Junhong Yang (7807046)

    Published 2025
    “…Notably, the incidence of VVRs decreased with increasing donor age. Additionally, the estimated incidences of VVRs were higher among female donors (13.600%) and first-time donors (18.536%) compared to male donors (11.205%) or repeat donors (5.819%). …”
  4. 60084

    A parameter sweep of <i>β</i> (rate of transition from uninfected (U) to eclipse phase (I1) cells) from 0.01x to 100x baseline reveals steady growth increases. by Josua O. Aponte-Serrano (9904912)

    Published 2021
    “…Tracking of cell types (U, I1, virus releasing, I2, and dead, D) for plaque growth dynamics corresponding to plaques in A. Center lines represent median over 20 replicas; shaded areas are the 5<sup>th</sup> and 95<sup>th</sup> percentiles. …”
  5. 60085

    Table_1_The WT1/MVP-Mediated Stabilization on mTOR/AKT Axis Enhances the Effects of Cisplatin in Non-small Cell Lung Cancer by a Reformulated Yu Ping Feng San Herbal Preparation.DO... by Jian-Shu Lou (5600207)

    Published 2018
    “…The anti-drug resistance of YPFS, triggered by an increase of intracellular concentration of DDP, was accompanied by an increased expression and activity of WT1, which consequently decreased the transcript level of MVP. In addition, the MVP-mediated downstream effector mTOR2/AKT was disrupted after application of YPFS<sub>+GF</sub> in DDP-treated A549/DDP cell: this disruption was characterized by the decline of mTORC2 components, e.g., Rictor, p-mTOR, as well as the phosphorylation level of its downstream protein AKT. …”
  6. 60086
  7. 60087

    Image_1_Perioperative lidocaine and dexmedetomidine intravenous infusion reduce the serum levels of NETs and biomarkers of tumor metastasis in lung cancer patients: A prospective,... by Baiqing Ren (14675129)

    Published 2023
    “…The patients were equally randomized to a placebo group (Group C), a lidocaine group (Group L, intravenous lidocaine 8 mg/kg/h for 15 minutes before anesthesia, 2 mg/kg/h during surgery, and 1 mg/kg/h until 24 hours after surgery), a dexmedetomidine group (Group D, intravenous dexmedetomidine 2 μg/kg/h for 15 minutes before anesthesia, 0.5 μg/kg/h during surgery, and 0.25 μg/kg/h until 24 hours after surgery), and a dexmedetomidine plus lidocaine group (Group LD, combination use of lidocaine and dexmedetomidine). …”
  8. 60088

    DataSheet2_ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validati... by Li Song (34475)

    Published 2024
    “…</p>Conclusion<p>This study points to ADRB2 as a promising biomarker with potential diagnostic and prognostic value in clinical cohort data. …”
  9. 60089

    DataSheet1_ADRB2 serves as a novel biomarker and attenuates alcoholic hepatitis via the SIRT1/PGC-1α/PPARα pathway: integration of WGCNA, machine learning and experimental validati... by Li Song (34475)

    Published 2024
    “…</p>Conclusion<p>This study points to ADRB2 as a promising biomarker with potential diagnostic and prognostic value in clinical cohort data. …”
  10. 60090

    Image1_A randomized, open-label, parallel pilot study investigating metabolic product kinetics of the novel ketone ester, bis-hexanoyl (R)-1,3-butanediol, over one week of ingestio... by Eunice Mah (5918042)

    Published 2023
    “…</p><p>Methods: We undertook a randomized, parallel, open-label study in healthy adults (n = 33) to elucidate blood BHB, HEX and BDO concentrations for 8 h following consumption of three different serving sizes (SS) of BH-BD (12.5, 25 and 50 g/day) before (Day 0) and after 7 days of daily BH-BD consumption (Day 7).…”
  11. 60091

    Relative change in catch for the last 20 years of projection for 50% increase in fishing effort of crustaceans (ICRUS50%), a 50% increase in fishing effort for crustaceans and finf... by Javier Porobic (6392612)

    Published 2019
    “…Note that the y-axes is the ratio of change against the starting conditions—so a -0.5 result indicates a 50% decrease and a 0.5 result indicates a 50% increase -.…”
  12. 60092

    S1 File - by Berhan Tekeba (15353895)

    Published 2024
    “…We included a total weighted sample of 74,871 reproductive-aged women who gave birth in the five years preceding the survey. …”
  13. 60093

    <i>skn-1b</i> is not required for WT or <i>daf-2</i> longevity A-F) Survival of WT and <i>skn-1b</i> mutants in the absence and presence of <i>daf-2</i> mutation. by Nikolaos Tataridas-Pallas (10231350)

    Published 2021
    “…We conclude that <i>skn-1b</i> does not contribute to <i>daf-2</i> longevity. In a total of 15 trials (13 on OP50, 2 on HT115) bacteria we observed a slight decrease in <i>skn-1b</i> longevity compared to WT in 4 trials (<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s004" target="_blank">S4</a> and <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009358#pgen.1009358.s005" target="_blank">S5</a> Tables). …”
  14. 60094
  15. 60095
  16. 60096
  17. 60097
  18. 60098

    Main effect neural results for participants with autism spectrum disorder (ASD) during real eye contact with ADOS-2 (Autism Diagnostic Observation Schedule, 2<sup>nd</sup> edition)... by Joy Hirsch (12408)

    Published 2022
    “…</b> Blue colors indicate a negative relationship between neural responses and ADOS scores indicating that as symptom severity increases, neural responsiveness in these regions decreases. …”
  19. 60099

    Table_1_Association of Elevated Plasma FGF21 and Activated FGF21 Signaling in Visceral White Adipose Tissue and Improved Insulin Sensitivity in Gestational Diabetes Mellitus Subtyp... by Ning Wang (108353)

    Published 2021
    “…Elevated circulating FGF21 concentration at delivery, increased FGF receptor 1c and decreased klotho beta gene expression, enhanced ERK1/2 phosphorylation, and increased GLUT1, IR-B, PPAR-γ gene expression in vWAT were found in the GDM-resistance group as compared with the NGT group. …”
  20. 60100

    Data_Sheet_1_Contrasting Association Between COVID-19 Vaccine Hesitancy and Mental Health Status in India and Saudi Arabia—A Preliminary Evidence Collected During the Second Wave o... by Saikarthik Jayakumar (12500296)

    Published 2022
    “…</p>Results<p>Prevalence and levels of depression and anxiety symptoms decreased significantly in Saudis but not in Indians after AC19V. …”